{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:07Z","timestamp":1790094547375,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05047-5","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:44:10Z","timestamp":1780919050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adult-onset ocular flutter\u2013opsoclonus spectrum across diverse neurological disorders: a video-oculographic case series"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-9822","authenticated-orcid":false,"given":"Pavol","family":"Skacik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-3082","authenticated-orcid":false,"given":"Stefan","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-6830","authenticated-orcid":false,"given":"Egon","family":"Kurca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"1","key":"5047_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/WCO.0b013e32835c5e1d","volume":"26","author":"J Lemos","year":"2013","unstructured":"Lemos J, Eggenberger E. Saccadic intrusions: review and update. Curr Opin Neurol. 2013;26(1):59\u201366.","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"5047_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","volume":"266","author":"SY Oh","year":"2019","unstructured":"Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019;266(6):1541\u20138.","journal-title":"J Neurol"},{"key":"5047_CR3","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1007\/s10072-024-07873-2","volume":"46","author":"F Certo","year":"2025","unstructured":"Certo F, Salvucci G, Casellato C, et al. Non-nystagmus hyperkinetic eye movement disorders. Neurol Sci. 2025;46:3021\u201338.","journal-title":"Neurol Sci"},{"issue":"5","key":"5047_CR4","doi-asserted-by":"publisher","first-page":"e200287","DOI":"10.1212\/NXI.0000000000200287","volume":"11","author":"A Farina","year":"2024","unstructured":"Farina A, Villagr\u00e1n-Garc\u00eda M, Benaiteau M, Lamblin F, Fourier A, Honnorat J, et al. Opsoclonus-ataxia syndrome in a patient with small-cell lung cancer treated with immune checkpoint inhibitors. Neurol Neuroimmunol Neuroinflamm. 2024;11(5):e200287.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"13","key":"5047_CR5","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1056\/NEJMicm1914516","volume":"383","author":"A Kunchok","year":"2020","unstructured":"Kunchok A, McKeon A. Opsoclonus in anti-Ma2 brain-stem encephalitis. N Engl J Med. 2020;383(13):e84.","journal-title":"N Engl J Med"},{"issue":"1","key":"5047_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","volume":"20","author":"A Wong","year":"2007","unstructured":"Wong A. An update on opsoclonus. Curr Opin Neurol. 2007;20(1):25\u201331.","journal-title":"Curr Opin Neurol"},{"key":"5047_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12311-022-01444-x","volume":"22","author":"M Manto","year":"2023","unstructured":"Manto M, Triarhou LC. Ocular dysmetria, flutter, and opsoclonus: refining the oculomotor deficits in cerebellar patients. Cerebellum. 2023;22:506\u201326.","journal-title":"Cerebellum"},{"issue":"5","key":"5047_CR8","first-page":"e84780","volume":"17","author":"JS Lawrence","year":"2025","unstructured":"Lawrence JS. Challenges in diagnosing opsoclonus-myoclonus syndrome in adults. Cureus. 2025;17(5):e84780.","journal-title":"Cureus"},{"issue":"5","key":"5047_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1055\/s-2006-955931","volume":"37","author":"K Rost\u00e1sy","year":"2006","unstructured":"Rost\u00e1sy K, Wilken B, Baumann M, M\u00fcller-Deile K, Bieber I, G\u00e4rtner J, et al. High-dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome. Neuropediatrics. 2006;37(5):291\u20135.","journal-title":"Neuropediatrics"},{"key":"5047_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","volume":"28","author":"MR Pranzatelli","year":"2006","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL, et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol. 2006;28:585\u201393.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5047_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37:1131\u201348.","journal-title":"Mov Disord"},{"issue":"11","key":"5047_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"key":"5047_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/brainsci15050518","volume":"15","author":"V P\u0103dureanu","year":"2025","unstructured":"P\u0103dureanu V, Dop D, P\u0103dureanu R, P\u00eer\u0219coveanu DFV, Olaru G, Streata I, et al. Anti-NMDA receptor encephalitis: a narrative review. Brain Sci. 2025;15:518.","journal-title":"Brain Sci"},{"key":"5047_CR14","doi-asserted-by":"publisher","first-page":"1388667","DOI":"10.3389\/fimmu.2024.1388667","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu Y, Tao Q, Dong Y, Zhang Y. Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis. Front Immunol. 2024;15:1388667.","journal-title":"Front Immunol"},{"issue":"6","key":"5047_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","volume":"73","author":"T Iizuka","year":"2016","unstructured":"Iizuka T, Kaneko J, Tominaga N, Someko H, Nakamura M, Ishima D, et al. Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol. 2016;73(6):706\u201313.","journal-title":"JAMA Neurol"},{"issue":"6","key":"5047_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nrl.2021.09.003","volume":"37","author":"J Valadez-Calderon","year":"2022","unstructured":"Valadez-Calderon J, Ordinola Navarro A, Rodriguez-Chavez E, Vera-Lastra O. Co-expression of anti-NMDAR and anti-GAD65 antibodies: a case of autoimmune encephalitis in a post-COVID-19 patient. Neurologia. 2022;37(6):503\u20134.","journal-title":"Neurologia"},{"issue":"4","key":"5047_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/CON.0000000000001457","volume":"30","author":"MC Dalakas","year":"2024","unstructured":"Dalakas MC. Stiff person syndrome and GAD antibody-spectrum disorders. Continuum (Minneap Minn). 2024;30(4):1110\u201335.","journal-title":"Continuum (Minneap Minn)"},{"issue":"7","key":"5047_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.21999","volume":"23","author":"T Anderson","year":"2008","unstructured":"Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord. 2008;23(7):977\u201384.","journal-title":"Mov Disord"},{"key":"5047_CR19","first-page":"211413","volume":"181","author":"X Ling","year":"2025","unstructured":"Ling X, Ma X, Wan Z, Sun Y, Li F, Wei L, et al. Ocular motor dysfunction in patients with multiple system atrophy and Parkinson\u2019s disease. Clin Neurophysiol. 2025;181:211413.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"5047_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/mdc3.13413","volume":"9","author":"P Kassavetis","year":"2022","unstructured":"Kassavetis P, Kaski D, Anderson T, Hallett M. Eye movement disorders in movement disorders. Mov Disord Clin Pract. 2022;9(3):284\u201395.","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"5047_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21790\/rvs.2024.026","volume":"24","author":"S Na","year":"2025","unstructured":"Na S, Hong YJ, Kim SH, Lee ES. Dizziness and neuro-otologic findings in neurodegenerative disorders: a review. Res Vestib Sci. 2025;24(2):68\u201378.","journal-title":"Res Vestib Sci"},{"issue":"1\u20132","key":"5047_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jns.2005.11.022","volume":"243","author":"J de Seze","year":"2006","unstructured":"de Seze J, Vukusic S, Viallet-Marcel M, Tilikete C, Z\u00e9phir H, Delalande S, et al. Unusual ocular motor findings in multiple sclerosis. J Neurol Sci. 2006;243(1\u20132):91\u20135.","journal-title":"J Neurol Sci"},{"issue":"3","key":"5047_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/WNO.0000000000000507","volume":"37","author":"E Nerrant","year":"2017","unstructured":"Nerrant E, Tilikete C. Ocular motor manifestations of multiple sclerosis. J Neuroophthalmol. 2017;37(3):332\u201340.","journal-title":"J Neuroophthalmol"},{"issue":"11","key":"5047_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/neurolint17110179","volume":"17","author":"P Skacik","year":"2025","unstructured":"Skacik P, Petrisin J, Sveda K, Turcanova-Koprusakova M, Grofik M, Sivak S, et al. Oculomotor abnormalities in anti-glutamic acid decarboxylase-positive stiff person syndrome. Neurol Int. 2025;17(11):179.","journal-title":"Neurol Int"},{"key":"5047_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/B978-0-444-52910-7.00042-8","volume":"112","author":"M Pike","year":"2013","unstructured":"Pike M. Opsoclonus-myoclonus syndrome. Handb Clin Neurol. 2013;112:1209\u201311.","journal-title":"Handb Clin Neurol"},{"key":"5047_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/eye.2014.276","volume":"29","author":"C Antoniades","year":"2015","unstructured":"Antoniades C, Kennard C. Ocular motor abnormalities in neurodegenerative disorders. Eye. 2015;29:200\u20137.","journal-title":"Eye"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05047-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:14:56Z","timestamp":1786576496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05047-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5047"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05047-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Ethics Committee of Jessenius Faculty of Medicine (Approval No. EK 32\/2023). Written informed consent to participate was obtained from all patients or their legal representatives.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of clinical data and accompanying images was obtained from all patients or their legal representatives.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"509"}}